<--- Back to Details
First PageDocument Content
Janssen Pharmaceutica / Multiple myeloma / B-cell chronic lymphocytic leukemia / Millennium Pharmaceuticals / Medicine / Oncology / Genmab
Date: 2013-05-01 14:24:34
Janssen Pharmaceutica
Multiple myeloma
B-cell chronic lymphocytic leukemia
Millennium Pharmaceuticals
Medicine
Oncology
Genmab

Media Inquiries: Kellie McLaughlin Phone: Mobile: Investor Relations: Stan Panasewicz

Add to Reading List

Source URL: www.janssenrnd.com

Download Document from Source Website

File Size: 53,76 KB

Share Document on Facebook

Similar Documents

Genmab A/S ToldbodgadeCopenhagen K Denmark Tel + Fax +

DocID: 1sjr0 - View Document

Economics / Funds / Investment / Genmab / Financial services

LSP Life Sciences Fund March 2013.xls

DocID: 1gEB0 - View Document

Evotec / Funds / Financial services / Collective investment schemes / Financial economics / Genmab / Investment

LSP Life Sciences Fund Monthly Report September 2013 € NAV per Share

DocID: 1gCcI - View Document

Investment / Financial services / Funds / Collective investment schemes / Financial economics / MorphoSys / Genmab

LSP Life Sciences Fund Monthly Report August 2013 € NAV per Share

DocID: 1gegX - View Document

Funds / Collective investment schemes / Genmab / Investment / Financial services

LSP Life Sciences Fund May.xls

DocID: 1fZaT - View Document